SLND Versus Non-Dissection Following ESD for T1a Stage Esophageal Squamous Cell Carcinoma

NANot yet recruitingINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

June 1, 2025

Primary Completion Date

January 1, 2027

Study Completion Date

April 1, 2027

Conditions
Esophageal Cancer
Interventions
PROCEDURE

Endoscopic Submucosal Dissection with Systematically mediastinal Lymph Node Dissection

Participants will be evaluated for inclusion criteria and exclusion criteria, and then sign informal consent if desired. Participants will be randomly assigned to the intervention according to a prepared random tables. Participants in the SLND group will receive Endoscopic Submucosal Dissection with systematically mediastinal lymph node dissection

PROCEDURE

Endoscopic Submucosal Dissection without SLND

Participants will be evaluated for inclusion criteria and exclusion criteria, and then sign informal consent if desired. Participants will be randomly assigned to the intervention according to a prepare random tables. Participants in the non-SLND group will just receive Endoscopic Submucosal Dissection treatment, not undergo Systematically mediastinal Lymph Node Dissection.

All Listed Sponsors
lead

Fujian Cancer Hospital

OTHER_GOV